Boswellia serrata extract — commonly known as Indian frankincense — is a resin-derived botanical extract obtained from the bark of the Boswellia serrata tree, native to India, the Middle East, and North Africa. For thousands of years, frankincense resin has been valued in Ayurvedic medicine for its anti-inflammatory and joint-supporting properties.
Modern extraction techniques isolate the bioactive boswellic acids — particularly AKBA (3-O-acetyl-11-keto-β-boswellic acid) — which are responsible for the extract's well-documented therapeutic effects. The standardized extract is available in powder form with boswellic acid content typically ranging from 10% to 65%+, depending on the extraction method and standardization level.
As a leading plant extract manufacturer, Greensky Bio supplies premium-grade Boswellia serrata extract to global customers in the dietary supplement, functional food, cosmetics, and pet health industries.
The therapeutic value of Boswellia serrata extract lies in its complex profile of pentacyclic triterpenic acids:
Compound Abbreviation Typical Content Primary Function 3-O-Acetyl-11-keto-β-boswellic acid AKBA 1–10%+ Most potent 5-LOX inhibitor 11-Keto-β-boswellic acid KBA 1–5% Anti-inflammatory, synergistic β-Boswellic acid (BA) BA 5–20% Base triterpenic acid 3-O-Acetyl-β-boswellic acid ABA 5–15% Anti-inflammatory α-Boswellic acid (α-BA) α-BA 2–8% Supporting activity
AKBA is the gold-standard marker compound — it is the most potent natural inhibitor of 5-lipoxygenase (5-LOX) identified to date. Premium extracts are standardized to specific AKBA percentages (e.g., 10%, 20%, or 30% AKBA), and this directly correlates with clinical efficacy and pricing.
Boswellia serrata extract works through a dual-pathway anti-inflammatory mechanism that distinguishes it from conventional NSAIDs and many other botanical extracts:
The enzyme 5-lipoxygenase (5-LOX) converts arachidonic acid into leukotrienes — powerful inflammatory mediators involved in:
Joint inflammation and cartilage degradation
Asthma and respiratory inflammation
Inflammatory bowel disease (IBD)
Chronic pain signaling
AKBA directly binds to the 5-LOX enzyme, preventing leukotriene synthesis without the gastrointestinal side effects associated with COX-inhibiting NSAIDs.
Boswellic acids also suppress the NF-κB transcription factor, reducing the expression of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6). This dual action — targeting both leukotriene production and cytokine signaling — makes Boswellia serrata one of the most comprehensive botanical anti-inflammatory agents available.
Unlike NSAIDs that inhibit COX enzymes (which can cause gastric ulcers), Boswellia selectively targets the 5-LOX pathway. This means it can be combined with COX-targeting ingredients like turmeric Curcumin for a broader anti-inflammatory spectrum.
Multiple randomized controlled trials have demonstrated that standardized Boswellia serrata extract (containing 30–65% boswellic acids or 10–30% AKBA) significantly reduces:
Joint pain and stiffness (improvements within 7–14 days)
Morning stiffness duration
Physical function scores (WOMAC index improvements of 20–45%)
Cartilage degradation markers
A 2019 meta-analysis of 8 RCTs (n=687) concluded that Boswellia serrata extract produced statistically significant improvements in pain, stiffness, and physical function compared to placebo in knee osteoarthritis patients.
Clinical studies have shown that Boswellia serrata extract can induce remission in patients with:
Ulcerative colitis (remission rates of 60–82% in clinical trials)
Crohn's disease (reduced disease activity index)
Microscopic colitis
The mechanism involves reduced leukotriene-mediated intestinal inflammation.
By inhibiting leukotriene synthesis, Boswellia serrata extract has shown benefits in:
Asthma management (reduced attack frequency, improved FEV1)
Allergic rhinitis
Chronic bronchitis
Topical and oral Boswellia serrata extract applications have demonstrated:
Reduced acne inflammation
Improved skin barrier function
Anti-aging properties through antioxidant activity
Both Boswellia serrata extract and turmeric Curcumin are premier anti-inflammatory botanicals. Understanding their differences helps formulators make evidence-based decisions.
Parameter Boswellia Serrata Extract Turmeric Curcumin Primary Target 5-LOX pathway (leukotrienes) COX-2 pathway (prostaglandins) Key Marker AKBA / Total Boswellic Acids Curcuminoids Onset of Action 7–14 days 4–8 weeks Bioavailability Moderate (enhanced with phospholipids) Low (requires piperine or liposomal) Joint Pain Efficacy ★★★★★ ★★★★☆ GI Comfort Excellent Good (high doses may irritate) Cancer Research Emerging Extensive Synergy Excellent with curcumin Excellent with boswellia
Research increasingly supports combining Boswellia serrata extract with turmeric curcumin for a synergistic effect. Together, they inhibit both the 5-LOX and COX-2 pathways — providing broader anti-inflammatory coverage than either compound alone.
As a botanical extract supplier experienced in both Boswellia serrata and turmeric curcumin production, Greensky Bio can supply both extracts with matched quality specifications for combination formulations.
Joint health capsules and tablets
Anti-inflammatory complexes (paired with curcumin, ginger, MSM)
Sports recovery formulas
Senior health supplements
Anti-inflammatory gummies and chews
Joint-support beverage powders
Functional tea blends
Anti-aging serums and creams
Acne treatment formulations
Post-sun recovery products
Scalp and hair care (anti-inflammatory)
Canine joint support supplements (rapidly growing market)
Equine anti-inflammatory formulas
Anti-aging pet nutrition
Greensky Bio's Boswellia serrata extract is manufactured under strict quality control standards. Below are our standard specifications:
Parameter Specification Test Method Appearance White to light yellow fine powder Organoleptic Odor Characteristic, resinous Organoleptic Boswellic Acids (Total) 10%, 30%, 50%, or 65% (customizable) HPLC AKBA 1–30%+ (customizable) HPLC KBA ≥ 1% HPLC Loss on Drying ≤ 5.0% USP <731> Ash Content ≤ 5.0% USP <281> Particle Size 80 mesh, 100 mesh, or custom Sieve Analysis Heavy Metals Pb ≤ 1.0 ppm, As ≤ 1.0 ppm, Cd ≤ 0.5 ppm, Hg ≤ 0.1 ppm ICP-MS Microbial Limits Total Plate Count ≤ 10,000 CFU/g, Yeast/Mold ≤ 1,000 CFU/g, E. coli: Negative, Salmonella: Negative USP <2021> Pesticide Residues Compliant with EU/USP limits GC-MS / LC-MS/MS Solvent Residues Compliant with ICH Q3C GC
Certificate Status ISO 22000 ✅ Certified HACCP ✅ Certified Kosher ✅ Certified Halal ✅ Certified Organic (EU/USDA) ✅ Available on request COA (per batch) ✅ Always provided Third-Party Lab Report ✅ Available (Eurofins, SGS)
Grade Boswellic Acid Content AKBA Content Typical Use Standard 10–30% 1–5% General wellness supplements Premium 40–50% 5–10% Targeted joint health, clinical-grade Super-Premium 60–65%+ 10–30%+ Pharmaceutical, high-end nutraceuticals
Green Flags (Good Signs):
Transparent HPLC chromatograms with clearly identified AKBA/KBA peaks
Batch-specific COAs with full heavy metals and microbial panels
Traceability to raw resin sourcing region (India, Somalia, Ethiopia)
Third-party verification (Eurofins, SGS, NSF)
Consistent supply with documented production capacity
Clear extraction method disclosure (ethanol, supercritical CO₂)
Red Flags (Warning Signs):
Only "total boswellic acids" listed without AKBA/KBA breakdown
No third-party lab verification
Unusually low pricing (may indicate adulteration with non-Boswellia resins)
Inconsistent color between batches (can indicate varying raw material quality)
No traceability documentation for raw material origin
Define your AKBA requirement based on your target efficacy and dosage
Request samples and run independent lab verification before committing
Verify extraction solvent — ethanol extraction is generally preferred for food-grade applications
Consider combination sourcing — a supplier experienced in both Boswellia and complementary extracts (curcumin, ginger) can streamline your supply chain
Negotiate long-term pricing with quality guarantees and supply stability clauses
Boswellia serrata extract is marketed as a dietary supplement ingredient under DSHEA
No GRAS designation is required for supplement use
New dietary ingredient (NDI) notification may be required for novel extracts
Generally recognized as safe (GRAS) for food use at traditional consumption levels
Listed in various EU national pharmacopoeias
Novel Food status may apply depending on extraction method and concentration
Compliant with EU Regulation (EC) No 178/2002 for food safety
Included in the Chinese Pharmacopoeia (乳香)
Available for dietary supplement formulation under China's health food regulations
Registration or filing may be required depending on product category
Generally well-tolerated in clinical trials at doses of 100–500 mg/day (standardized extracts)
Mild GI discomfort is the most commonly reported adverse event
No known significant drug interactions, but caution with anticoagulants
Not recommended during pregnancy due to limited safety data
LD₅₀ studies indicate a wide safety margin
Greensky Bio is a trusted plant extract manufacturer and botanical extract supplier specializing in premium herbal extracts from China. Our Boswellia serrata extract benefits from:
Standardized to your specification — from 10% to 65%+ total boswellic acids, with precise AKBA control
Advanced extraction technology — ethanol and supercritical CO₂ methods for maximum bioactive preservation
Full-spectrum and enriched options — choose the profile that fits your formulation
ISO 22000, HACCP, Kosher, Halal, Organic certified facilities
Every batch tested — HPLC verification of AKBA, KBA, and total boswellic acids
Third-party lab verification available through Eurofins and SGS
Complete documentation — COA, TSE/BSE-free statement, allergen statement, non-GMO declaration
Beyond Boswellia serrata, Greensky Bio produces a comprehensive range of herbal extracts in China, including:
Saw Palmetto Extract — prostate health
Astaxanthin — antioxidant powerhouse
Red Yeast Rice Extract — cardiovascular support
Artichoke Extract — liver and digestive health
Turmeric Curcumin Extract — synergistic anti-inflammatory partner for Boswellia
Consistent supply with documented production capacity and inventory management
Competitive pricing through direct sourcing from Indian resin suppliers
Flexible MOQ to support both startups and established brands
Custom packaging — bulk drums, retail-ready bags, or private label ready
Standard extracts are typically standardized to total boswellic acids (e.g., 30%, 50%, 65%), while AKBA-enriched extracts specifically target the most potent anti-inflammatory compound (AKBA) at higher concentrations (10–30%+). AKBA-enriched extracts command a premium price but offer superior clinical efficacy at lower dosages.
Clinical studies commonly use 100–500 mg/day of standardized Boswellia serrata extract (30–65% boswellic acids). For AKBA-enriched extracts (10–30% AKBA), dosages of 50–200 mg/day have shown efficacy.
Yes — this is one of the most popular and evidence-based combinations in the joint health market. The two compounds target complementary inflammatory pathways (5-LOX and COX-2), providing broader anti-inflammatory coverage. Greensky Bio supplies both extracts, making combination sourcing seamless.
Store in a cool, dry place away from direct sunlight. Recommended storage temperature is below 25°C (77°F) with relative humidity below 60%. Properly stored, the extract maintains stability for 24 months from the manufacturing date.
Yes, our Boswellia serrata extract is plant-derived, vegan-friendly, and free from all major allergens (gluten, dairy, soy, nuts, shellfish). We provide allergen-free declarations with each order.
We offer both ethanol extraction and supercritical CO₂ extraction. Ethanol extraction is the most common for food-grade applications, while supercritical CO₂ provides a solvent-free extract with a broader terpene profile. We can customize the extraction method based on your requirements.
Yes. While we maintain standard specifications (30%, 50%, 65% boswellic acids), we can customize the AKBA content, total boswellic acid percentage, and particle size to match your formulation needs.
Our standard MOQ is 1 kg for evaluation orders, with bulk pricing available for orders of 25 kg and above. Contact our sales team for custom pricing and volume discounts.
Ready to source premium Boswellia Serrata Extract?
Contact Greensky Bio — your trusted plant extract manufacturer and botanical extract supplier — for competitive pricing, free samples, and expert formulation support.
Email: [email protected] Website:
2026-11-14
2026-11-14
2026-11-14
2026-11-14
2026-11-14
2026-11-14
2026-11-14
2026-11-14
2026-11-14
2026-11-14